1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with Benign Meningeal Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Caire, F; De Armas, R; Denizot, Y; Labrousse, F; Pommepuy, I; Truffinet, V | 1 |
| Endo, S; Fukuda, O; Hayashi, N; Hirashima, Y; Ito, H; Takaku, A | 1 |
2 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Benign Meningeal Neoplasms
| Article | Year |
|---|---|
Platelet-activating factor and human meningiomas.
Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Adult; Aged; Biomarkers, Tumor; Female; Humans; Male; Meningeal Neoplasms; Meningioma; Middle Aged; Neovascularization, Pathologic; Phospholipases A; Phospholipases A2; Platelet Activating Factor; Platelet Membrane Glycoproteins; Receptors, G-Protein-Coupled; Reverse Transcriptase Polymerase Chain Reaction; Transcription, Genetic | 2006 |
Platelet-activating factor and edema surrounding meningiomas.
Topics: Adult; Aged; Brain Edema; Female; Humans; Immunohistochemistry; Leukocytes; Male; Meningeal Neoplasms; Meningioma; Middle Aged; Osmolar Concentration; Platelet Activating Factor | 1998 |